QFITLIA J Code: J7174

Drug & Product Overview

HCPCS Descriptor Injection, fitusiran, 0.04 mg

HCPCS Added Date October 1, 2025

Manufacturer Sanofi

Route of Administration Subcutaneous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Solution

About QFITLIA

Qfitlia is a medication aligned to the HCPCS J Code: J7174 for billing, pricing, and reimbursement purposes in the United States. It is a Hematology drug administered via the subcutaneous route and manufactured by Sanofi.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
58468-0347-01	Qfitlia	Genzyme Corporation	500	20 MG / 0.2 ML
58468-0348-01	Qfitlia	Genzyme Corporation	1250	50 MG / 0.5 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

QFITLIA Pricing & Reimbursement

J7174 Private Payer Reimbursement

$132.24 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

Fitusiran 505(b)(2) Information:

HCPCS Code	Manufacturer	Active Ingredient	HCPCS Description
J7174	Sanofi	Fitusiran	Injection, fitusiran, 0.04 mg

QFITLIA CPT Administration Codes

CPT Code	Description
96372	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

QFITLIA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Hemophilia A or B with or without factor VIII or IX inhibitors

Drug Class

Antithrombin-directed RNA Interaction [EPC]Decreased RNA Integrity [PE]Increased RNA Degradation [PE]RNASmall Interfering [CS]Small Interfering RNA [EPC]

Frequently Asked Questions

Is there an available Qfitlia billing and coding guide?

Billing and coding information for QFITLIA can be found through Genzyme Corporation. Visit Here →

Are there any available Qfitlia patient assistance programs?

QFITLIA patient assistance information can be found through Genzyme Corporation. Visit Here →

Where can I find Qfitlia prescribing information?

Qfitlia prescribing information can be found through the link below. Visit Here →

Where can I find Qfitlia side effect information?

Qfitlia side effect information can be found at the link below. Visit Here →

Does billing Qfitlia require wastage modifiers?

CMS does not include QFITLIA (J7174) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J7174. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.